• Explore /
  • Poster
  • / Risks of severe adverse events of docetaxel, cisplatin, and 5-fluorouracil (DCF) combination chemotherapy of esophageal cancer.

Risks of severe adverse events of docetaxel, cisplatin, and 5-fluorouracil (DCF) combination chemotherapy of esophageal cancer.

Abstract Poster

Authors

null

Sayako Yuda

Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan

Sayako Yuda , Ken Kato , Yusuke Sasaki , Naoki Takahashi , Hirokazu Shoji , Atsuo Takashima , Natsuko T. Okita , Yoshitaka Honma , Satoru Iwasa , Tetsuya Hamaguchi , Yasuhide Yamada , Kengo Nagashina , Narikazu Boku

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Prevention, Diagnosis, and Screening

Citation

J Clin Oncol 33, 2015 (suppl 3; abstr 43)

DOI

10.1200/jco.2015.33.3_suppl.43

Abstract #

43

Poster Bd #

A43

Abstract Disclosures

Similar Posters

First Author: Go Ikeda

First Author: Go Ikeda

First Author: Ajaykumar Singh

First Author: S.P. Somashekhar